First published 9/28/2026, 4:33:15 AM · Last updated 9/28/2026, 4:33:30 AM

Development and Validation of a Novel Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry Method for Serum 3-Epi-25-Hydroxyvitamin D 3 , 25-Hydroxyvitamin D 3 , and 25-Hydroxyvitamin D 2

Journal article reports development and validation of a novel ultraperformance liquid chromatography–tandem mass spectrometry method for measuring serum 3-epi-25-hydroxyvitamin D3, 25-hydroxyvitamin D3, and 25-hydroxyvitamin D2. Published in Laboratory Medicine Online on 2026-10-01.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 7/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

Provides a validated analytical method for measuring specific serum vitamin D metabolites.

Sources

Development and Validation of a Novel Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry Method for Serum 3-Epi-25-Hydroxyvitamin D 3 , 25-Hydroxyvitamin D 3 , and 25-Hydroxyvitamin D 2

Report an issue

Development and Validation of a Novel Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry Method for Serum 3-Epi-25-Hydroxyvitamin D <sub>3</sub> , 25-Hydroxyvitamin D <sub>3</sub> , and 25-Hydroxyvitamin D <sub>2</sub>

Generated scores

Why it matters

Sources